Rapid detection of the ultraextensive metabolizer associated CYP2D6*35 polymorphism.

被引：0
|
作者：
Steimer, W [1 ]
Bachofer, J [1 ]
Leucht, S [1 ]
Müller, B [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
B20
引用
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [1] Rapid detection of the intermediate metabolizer associated CYP2D6 polymorphisms*9 and*17 with real time PCR
    Steimer, W
    Müller, T
    Popp, J
    Heres, S
    Kissling, W
    Leucht, S
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 242 - 243
  • [2] Are you sure the patient is a CYP2D6 ultra-rapid metabolizer?
    Gregg, Keqin
    Guo, Wenjing
    Rhodes, Robert
    Simhadri, Ashrita
    Subramanya, Archana
    Samilpa, Paul
    Langley, Lyndsey
    Ames, Kyle
    McCarty, Matt
    PHARMACOGENOMICS, 2016, 17 (16) : 1749 - 1763
  • [3] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [4] CYP2D6 polymorphism is not associated with essential tremor
    Agundez, JAG
    JimenezJimenez, FJ
    Tejeda, R
    Ledesma, MC
    OrtiPareja, M
    Gasalla, T
    Molina, JA
    Ruiz, J
    Coria, F
    Duarte, J
    Vazquez, A
    Ladero, JM
    Benitez, J
    EUROPEAN NEUROLOGY, 1997, 38 (02) : 99 - 104
  • [5] Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype:: a role for the CYP2D6*35 allele in ultrarapid metabolism?
    Lovlie, R
    Daly, AK
    Matre, GE
    Molven, A
    Steen, VM
    PHARMACOGENETICS, 2001, 11 (01): : 45 - 55
  • [6] Lack of within-family association of spondylarthropathy (SpA) with CYP2D6 polymorphism.
    Richard, CM
    Lesage, S
    Zouali, H
    Nahal, RS
    Thomas, G
    Breban, M
    Hugot, JP
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S239 - S239
  • [7] Rapid detection of the C-1496G polymorphism in the CYP2D6*2 allele
    Claassen, JD
    Pascoe, N
    Schatzberg, AF
    Murphy, GM
    CLINICAL CHEMISTRY, 2001, 47 (12) : 2153 - 2155
  • [8] CYP2D6 metabolizer status and postoperative analgesia with tramadol
    Wilder-Smith, CH
    Wilkins, J
    ANESTHESIOLOGY, 1999, 91 (3A) : U416 - U416
  • [9] The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer
    AbdelRahman, SZ
    Anwar, WA
    AbdelAal, WE
    Ghoneim, MA
    Au, WW
    CANCER LETTERS, 1997, 119 (01) : 115 - 122
  • [10] On the impact of the CYP2D6 ultra-rapid metabolizer genotype on mirtazapine pharmacokinetics.
    Brockmöller, J
    Kirchheiner, J
    Henckel, H
    Meineke, I
    Roots, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P67 - P67
12345